Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
Journal of Hepatology|January 2, 2007
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosisHerbert L Bonkovsky, Kristin K Snow, Peter F Malet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 11, 2019
HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype DefinitionWillem P Brouwer, Qian Zhao, Bettina E Hansen, et al.
Hepatology (Baltimore, Md.)|December 25, 2007
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) TrialLeonard B Seeff, Teresa M Curto, Gyongyi Szabo, et al.
Gastroenterology|September 15, 2009
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trialMitchell L Shiffman, Chihiro Morishima, Jules L Dienstag, et al.
Gastroenterology|January 24, 2007
Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis CMitchell L Shiffman, Marc G Ghany, Timothy R Morgan, et al.
Contemporary Clinical Trials|March 27, 2017
Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatmentDonna M Evon, Carol E Golin, Paul Stewart, et al.
Vaccine|July 13, 2010
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adultsSharon E Frey, Michael Houghton, Stephen Coates, et al.
Controlled Clinical Trials|October 7, 2004
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonrespondersWilliam M Lee, Jules L Dienstag, Karen L Lindsay, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trialGregory T Everson, John C Hoefs, Leonard B Seeff, et al.
Hepatology Communications|October 9, 2019
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET AnalysisKavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, et al.
Pageof 20